Registered Trials
-
NCT04691908
Phase 3Kazakhstan
Total Enrollment: 3,000
Official Trial Registration:
-
NCT04530357
Phase 1/2Kazakhstan
Total Enrollment: 244
Official Trial Registration:
This site is no longer being updated. Data are accurate as of 2 Dec 2022.
© 2023 VIPER Group COVID19 Vaccine Tracker Team
Funding provided by the McGill University Interdisciplinary Initiative in Infection and Immunity (MI4)
This site is provided for informational purposes only based on publically available data.